More Information
Summary:The present invention relates to novel compounds of formula I:which have the properties of CDK8/19 inhibitors, to a pharmaceutical composition comprising said compounds, and to use thereof as a medicine for treating diseases and disorders.
Bibliography:Application Number: US201917264670